Trial record 1 of 1 for:
56021927PCR3015 | cancer | Finland
A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer (PRIMORDIUM)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04557059 |
|
Recruitment Status :
Recruiting
First Posted : September 21, 2020
Last Update Posted : April 24, 2024
|
Sponsor:
Janssen Pharmaceutica N.V., Belgium
Information provided by (Responsible Party):
Janssen Pharmaceutica N.V., Belgium
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | August 27, 2029 |
| Estimated Study Completion Date : | August 27, 2029 |